ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 294980 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 294980; 2) Community: the network communities that were significantly associated with the response to NSC 294980; 3) Molecule: the relationships between components within communities and NSC 294980; 4) MDR: the compounds that were significantly associated with the NSC 294980.

NSC Compound Enrichment Correlation
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0062609247058654 0.18841417
NSC 717838 Null 0.00626092470586549 -0.1159668
NSC 314622 Indenoisoquinoline derivative 0.00662388971299138 0.70139343
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.00662388971299138 0.43976502
NSC 610459 Camptothecin Derivative 0.00662388971299138 0.72070516
NSC 638441 Null 0.00662388971299138 0.43636579
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00662388971299138 0.36950207
NSC 680300 Null 0.00662388971299138 0.37975142
NSC 697189 Null 0.00662388971299138 0.43098686
NSC 740564 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.00662388971299138 0.53001748
Total:72  Current:11    [First] [Prev] [Next] [Last]